Bepotastine Besilate Ophthalmic Solution 1.5% Articles
ISTA's Bepreve NDA accepted by FDA
26 January 2009
ISTA files Bepreve NDA in USA
24 November 2008
More positive results for ISTA's Bepreve
12 May 2008
ISTA engages advisor to view future
7 April 2008
Showing 1-4 of 4 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
